Attached files
file | filename |
---|---|
10-Q - QUARTERLY REPORT 12-31-2009 - OMNI BIO PHARMACEUTICAL, INC. | omnibio10q123109_2310.htm |
EX-10.2 - EXHIBIT 10.2 - OMNI BIO PHARMACEUTICAL, INC. | omnibio10q123109x102_2310.htm |
EX-31.2 - EXHIBIT 31.2 - OMNI BIO PHARMACEUTICAL, INC. | omnibio10q123109x312_2310.htm |
EX-10.3 - EXHIBIT 10.3 - OMNI BIO PHARMACEUTICAL, INC. | omnibio10q123109x103_2310.htm |
EX-31.1 - EXHIBIT 31.1 - OMNI BIO PHARMACEUTICAL, INC. | omnibio10q123109x311_2310.htm |
EX-32.2 - EXHIBIT 32.2 - OMNI BIO PHARMACEUTICAL, INC. | omnibio10q123109x322_2310.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Omni Bio Pharmaceutical, Inc. (the
“Company”) on Form 10-Q for the quarter ended December 31, 2009 (the “Report”),
I, Charles A. Dinarello, Acting Chief Executive Officer of the Company, hereby
certify that, to the best of my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company for the period
covered by this report.
Date: February
4, 2010
|
/s/ Charles A.
Dinarello
|
Charles
A. Dinarello
|
|
Acting
Chief Executive Officer
|